Showing results (101-110 of 177) with videos related to
Sort By:
Pageof 18
American Journal of Clinical Oncology|December 18, 2018
The Outcome of Patients With Localized Undifferentiated Pleomorphic Sarcoma of the Lower Extremity Treated at Stanford UniversityNikhil V Kamat, Lynn Million, Dong-Han Yao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma StudyMoody D Wharam, Jane Meza, James Anderson, et al.Pediatric Blood & Cancer|April 12, 2021
Esophageal disease among childhood cancer survivors-A report from the Childhood Cancer Survivors StudyPeter H Asdahl, Kevin C Oeffinger, Vanna Albieri, et al.Pediatric Blood & Cancer|August 14, 2020
Training and education of pediatric radiation oncologists: A survey from the 2019 Pediatric Radiation Oncology Society meetingArnold C Paulino, Karin Dieckmann, Natia Esiashvili, et al.Pediatric Blood & Cancer|April 5, 2021
RhabdomyosarcomaRaphael L Yechieli, Henry C Mandeville, Susan M Hiniker, et al.Journal of Neuro-Oncology|May 24, 2017
Chemoradiation impairs normal developmental cortical thinning in medulloblastomaPalak Kundu, Matthew D Li, Ben Y Durkee, et al.Cancer|June 4, 2025
Extremity rhabdomyosarcoma in children, adolescents and young adults: A report from Children's Oncology Group trialsSapna Oberoi, Wei Xue, Amira Qumseya, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2006
Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology GroupTorunn I Yock, Mark Krailo, Christopher J Fryer, et al.Cancer|May 9, 2019
Risk-based treatment for patients with first relapse or progression of rhabdomyosarcoma: A report from the Children's Oncology GroupLeo Mascarenhas, Elizabeth R Lyden, Philip P Breitfeld, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2010
Randomized phase II window trial of two schedules of irinotecan with vincristine in patients with first relapse or progression of rhabdomyosarcoma: a report from the Children's Oncology GroupLeo Mascarenhas, Elizabeth R Lyden, Philip P Breitfeld, et al.Pageof 18